![Dr. Sergio Vañó on Twitter: "The use of low dose oral dutasteride combined with 5% topical minoxidil 4-5/week may improve patients with early #AndrogeneticAlopecia, with an excellent long-term compliance. Topical minoxidil may Dr. Sergio Vañó on Twitter: "The use of low dose oral dutasteride combined with 5% topical minoxidil 4-5/week may improve patients with early #AndrogeneticAlopecia, with an excellent long-term compliance. Topical minoxidil may](https://pbs.twimg.com/media/D4gz30BXsAEauov.jpg)
Dr. Sergio Vañó on Twitter: "The use of low dose oral dutasteride combined with 5% topical minoxidil 4-5/week may improve patients with early #AndrogeneticAlopecia, with an excellent long-term compliance. Topical minoxidil may
![Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00448-x/MediaObjects/13555_2020_448_Fig1_HTML.jpg)
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink
![Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients Dey VK - Indian J Paediatr Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients Dey VK - Indian J Paediatr](https://www.ijpd.in/articles/2016/17/3/images/IndianJPaediatrDermatol_2016_17_3_173_179484_f3.jpg)
Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients Dey VK - Indian J Paediatr
Rogaine Foam/ Minoxidil, Ethiopia - If your hair has just started to thin, don't worry. The right haircut (shorter, with blunt lines) can help a lot. And if you need a long-term
![Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41702-019-0046-y/MediaObjects/41702_2019_46_Fig2_HTML.png)
Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text
![Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment - Journal of the American Academy of Dermatology Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9cb65b1b-86f8-43ce-a079-f0022b05d693/gr1.jpg)
Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment - Journal of the American Academy of Dermatology
![Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment - Journal of the American Academy of Dermatology Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005261650/2022455846/gr3.jpg)